CN Patent

CN110191707A — Rad1901-2hcl的多晶型形式

Assigned to Radius Pharmaceuticals Inc · Expires 2019-08-30 · 7y expired

What this patent protects

制备并表征了RAD1901‑2HCl的各种多晶型形式，包括三种结晶和无定形形式。还公开了RAD1901‑2HCl的各种多晶型形式在癌症治疗中的应用。

USPTO Abstract

制备并表征了RAD1901‑2HCl的各种多晶型形式，包括三种结晶和无定形形式。还公开了RAD1901‑2HCl的各种多晶型形式在癌症治疗中的应用。

Drugs covered by this patent

elacestrant-hydrochloride (ELACESTRANT HYDROCHLORIDE)

Patent Metadata

Patent number: CN110191707A
Jurisdiction: CN
Classification: —
Expires: 2019-08-30
Drug substance claim: No
Drug product claim: No
Assignee: Radius Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.